Clinical and functional characterization of two novel ZBTB20 mutations causing Primrose syndrome

Emilia Stellacci, Katharina Steindl, Pascal Joset, Laura Mercurio, Massimiliano Anselmi, Serena Cecchetti, Laura Gogoll, Markus Zweier, Annette Hackenberg, Gianfranco Bocchinfuso, Lorenzo Stella, Marco Tartaglia, Anita Rauch

Research output: Contribution to journalArticle

Abstract

Primrose syndrome (PS) is a rare disorder characterized by macrocephaly, tall stature, intellectual disability, autistic traits, and disturbances of glucose metabolism with insulin-resistant diabetes and distal muscle wasting occurring in adulthood. The disorder is caused by functional dysregulation of ZBTB20, a transcriptional repressor controlling energetic metabolism and developmental programs. ZBTB20 maps in a genomic region that is deleted in the 3q13.31 microdeletion syndrome, which explains the clinical overlap between the two disorders. A narrow spectrum of amino acid substitutions in a restricted region of ZBTB20 encompassing the first and second zinc-finger motifs have been reported thus far. Here, we characterize clinically and functionally the first truncating mutation [(c.1024delC; p.(Gln342Serfs*42)] and a missense change affecting the third zinc-finger motif of the protein [(c.1931C > T; p.(Thr644Ile)]. Our data document that both mutations have dominant negative impact on wild-type ZBTB20, providing further evidence of the specific behavior of PS-causing mutations on ZBTB20 function.

Original languageEnglish
Pages (from-to)959-964
Number of pages6
JournalHuman Mutation
Volume39
Issue number7
DOIs
Publication statusPublished - Jul 2018

Fingerprint

Zinc Fingers
Mutation
Megalencephaly
Amino Acid Substitution
Protein C
Intellectual Disability
Insulin
Glucose
Muscles
Primrose syndrome

Cite this

Clinical and functional characterization of two novel ZBTB20 mutations causing Primrose syndrome. / Stellacci, Emilia; Steindl, Katharina; Joset, Pascal; Mercurio, Laura; Anselmi, Massimiliano; Cecchetti, Serena; Gogoll, Laura; Zweier, Markus; Hackenberg, Annette; Bocchinfuso, Gianfranco; Stella, Lorenzo; Tartaglia, Marco; Rauch, Anita.

In: Human Mutation, Vol. 39, No. 7, 07.2018, p. 959-964.

Research output: Contribution to journalArticle

Stellacci, E, Steindl, K, Joset, P, Mercurio, L, Anselmi, M, Cecchetti, S, Gogoll, L, Zweier, M, Hackenberg, A, Bocchinfuso, G, Stella, L, Tartaglia, M & Rauch, A 2018, 'Clinical and functional characterization of two novel ZBTB20 mutations causing Primrose syndrome', Human Mutation, vol. 39, no. 7, pp. 959-964. https://doi.org/10.1002/humu.23546
Stellacci, Emilia ; Steindl, Katharina ; Joset, Pascal ; Mercurio, Laura ; Anselmi, Massimiliano ; Cecchetti, Serena ; Gogoll, Laura ; Zweier, Markus ; Hackenberg, Annette ; Bocchinfuso, Gianfranco ; Stella, Lorenzo ; Tartaglia, Marco ; Rauch, Anita. / Clinical and functional characterization of two novel ZBTB20 mutations causing Primrose syndrome. In: Human Mutation. 2018 ; Vol. 39, No. 7. pp. 959-964.
@article{24c6f773b5e54e389d71492b19127ad6,
title = "Clinical and functional characterization of two novel ZBTB20 mutations causing Primrose syndrome",
abstract = "Primrose syndrome (PS) is a rare disorder characterized by macrocephaly, tall stature, intellectual disability, autistic traits, and disturbances of glucose metabolism with insulin-resistant diabetes and distal muscle wasting occurring in adulthood. The disorder is caused by functional dysregulation of ZBTB20, a transcriptional repressor controlling energetic metabolism and developmental programs. ZBTB20 maps in a genomic region that is deleted in the 3q13.31 microdeletion syndrome, which explains the clinical overlap between the two disorders. A narrow spectrum of amino acid substitutions in a restricted region of ZBTB20 encompassing the first and second zinc-finger motifs have been reported thus far. Here, we characterize clinically and functionally the first truncating mutation [(c.1024delC; p.(Gln342Serfs*42)] and a missense change affecting the third zinc-finger motif of the protein [(c.1931C > T; p.(Thr644Ile)]. Our data document that both mutations have dominant negative impact on wild-type ZBTB20, providing further evidence of the specific behavior of PS-causing mutations on ZBTB20 function.",
author = "Emilia Stellacci and Katharina Steindl and Pascal Joset and Laura Mercurio and Massimiliano Anselmi and Serena Cecchetti and Laura Gogoll and Markus Zweier and Annette Hackenberg and Gianfranco Bocchinfuso and Lorenzo Stella and Marco Tartaglia and Anita Rauch",
note = "{\circledC} 2018 Wiley Periodicals, Inc.",
year = "2018",
month = "7",
doi = "10.1002/humu.23546",
language = "English",
volume = "39",
pages = "959--964",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Clinical and functional characterization of two novel ZBTB20 mutations causing Primrose syndrome

AU - Stellacci, Emilia

AU - Steindl, Katharina

AU - Joset, Pascal

AU - Mercurio, Laura

AU - Anselmi, Massimiliano

AU - Cecchetti, Serena

AU - Gogoll, Laura

AU - Zweier, Markus

AU - Hackenberg, Annette

AU - Bocchinfuso, Gianfranco

AU - Stella, Lorenzo

AU - Tartaglia, Marco

AU - Rauch, Anita

N1 - © 2018 Wiley Periodicals, Inc.

PY - 2018/7

Y1 - 2018/7

N2 - Primrose syndrome (PS) is a rare disorder characterized by macrocephaly, tall stature, intellectual disability, autistic traits, and disturbances of glucose metabolism with insulin-resistant diabetes and distal muscle wasting occurring in adulthood. The disorder is caused by functional dysregulation of ZBTB20, a transcriptional repressor controlling energetic metabolism and developmental programs. ZBTB20 maps in a genomic region that is deleted in the 3q13.31 microdeletion syndrome, which explains the clinical overlap between the two disorders. A narrow spectrum of amino acid substitutions in a restricted region of ZBTB20 encompassing the first and second zinc-finger motifs have been reported thus far. Here, we characterize clinically and functionally the first truncating mutation [(c.1024delC; p.(Gln342Serfs*42)] and a missense change affecting the third zinc-finger motif of the protein [(c.1931C > T; p.(Thr644Ile)]. Our data document that both mutations have dominant negative impact on wild-type ZBTB20, providing further evidence of the specific behavior of PS-causing mutations on ZBTB20 function.

AB - Primrose syndrome (PS) is a rare disorder characterized by macrocephaly, tall stature, intellectual disability, autistic traits, and disturbances of glucose metabolism with insulin-resistant diabetes and distal muscle wasting occurring in adulthood. The disorder is caused by functional dysregulation of ZBTB20, a transcriptional repressor controlling energetic metabolism and developmental programs. ZBTB20 maps in a genomic region that is deleted in the 3q13.31 microdeletion syndrome, which explains the clinical overlap between the two disorders. A narrow spectrum of amino acid substitutions in a restricted region of ZBTB20 encompassing the first and second zinc-finger motifs have been reported thus far. Here, we characterize clinically and functionally the first truncating mutation [(c.1024delC; p.(Gln342Serfs*42)] and a missense change affecting the third zinc-finger motif of the protein [(c.1931C > T; p.(Thr644Ile)]. Our data document that both mutations have dominant negative impact on wild-type ZBTB20, providing further evidence of the specific behavior of PS-causing mutations on ZBTB20 function.

U2 - 10.1002/humu.23546

DO - 10.1002/humu.23546

M3 - Article

C2 - 29737001

VL - 39

SP - 959

EP - 964

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 7

ER -